LFCR — Lifecore Biomedical Balance Sheet
0.000.00%
- $272.88m
- $395.05m
- $128.87m
- 24
- 37
- 95
- 51
Annual balance sheet for Lifecore Biomedical, fiscal year end - May 25th, USD millions except per share, conversion factor applied.
2021 May 30th | R2022 May 29th | 2023 May 28th | 2024 May 26th | 2025 May 25th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1.29 | 0.991 | 19.1 | 8.46 | 8.27 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 70 | 38.3 | 29 | 31.2 | 43.7 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 148 | 117 | 93.9 | 81 | 85.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 200 | 124 | 139 | 151 | 129 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 503 | 275 | 254 | 254 | 239 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 102 | 177 | 39.3 | 38.9 | 30.2 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 300 | 187 | 218 | 200 | 192 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 203 | 87.8 | 35.1 | 53.9 | 47.4 |
Total Liabilities & Shareholders' Equity | 503 | 275 | 254 | 254 | 239 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |